The study compared distant-stage incidence and cancer-specific mortality trends across ten US solid cancers, 2004-2023, by Joinpoint regression. Of 5,545,600 incident cancers, 1,060,790 were diagnosed at distant stage. Breast and prostate cancer and melanoma had rising distant-stage incidence but falling mortality. Lung and colorectal cancers fell on both measures, while pancreatic, liver and uterine cancers rose on both. All ten paired patterns were unchanged in a common 2004-2019 window. Incidence came from SEER17 registries but mortality was national, so the two measures cover different populations.
Why it is interesting: For breast and prostate cancer, distant-stage incidence and mortality moved in opposite directions. Pancreatic, liver and uterine cancers worsened on both measures over two decades.
Cite this item
BibTeX
Free sign-up. A digest of the new papers twice a week, grouped by domain.